83 results
S-8
NRIX
Nurix Therapeutics Inc
23 Jul 20
Registration of securities for employees
9:28pm
the 2020 Plan. See footnote 6 below.
Calculated solely for the purpose of this offering under Rules 457(h) and 457(c) of the Securities Act … Plan (“Purchase Plan”).
Calculated solely for the purpose of this offering under Rule 457(h) of the Securities Act and on the basis of the initial
S-1/A
EX-10.4
NRIX
Nurix Therapeutics Inc
20 Jul 20
IPO registration (amended)
6:32am
in Section 27.
2. Purpose. The purpose of this Plan is to provide eligible employees of the Company and Participating Corporations with a means … received or held by the Company may be used by the Company for any corporate purpose, except to the extent necessary to comply with local legal
DRS
EX-3.3
NRIX
Nurix Therapeutics Inc
5 May 20
Draft registration statement
12:00am
. Annual Meeting.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business … meetings of the stockholders of the corporation may be called, for any purpose or purposes, by (i) the Chairman of the Board of Directors, (ii) the Chief
S-1
EX-3.3
NRIX
Nurix Therapeutics Inc
2 Jul 20
IPO registration
4:04pm
Meeting.
(a) The annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as may … of the stockholders of the corporation may be called, for any purpose or purposes, by (i) the Chairman of the Board of Directors, (ii) the Chief
S-3ASR
EX-4.3
NRIX
Nurix Therapeutics Inc
4 Aug 21
Automatic shelf registration
4:11pm
of (and premium, if any, on) and [any such] interest on this Security will be made at the office or agency of the Company maintained for that purpose … benefit under the Indenture or be valid or obligatory for any purpose.
IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed
S-8
iahsvn2bu0mrumym4c
15 Feb 24
Registration of securities for employees
4:51pm
S-1
EX-3.1
1eqzrbv90 4u
2 Jul 20
IPO registration
4:04pm
S-1/A
EX-3.4
0d7aqu
20 Jul 20
IPO registration (amended)
6:32am
S-1/A
EX-3.1
0hjmwf249i7
20 Jul 20
IPO registration (amended)
6:32am
8-K
EX-3.1
19ze6
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
10-Q
EX-3.2
hqxr2hf h7e
14 Oct 20
Quarterly report
4:02pm
S-8
9hi zp9qc5uw
28 Jan 22
Registration of securities for employees
4:55pm
S-1/A
EX-10.3
gde1xtg
20 Jul 20
IPO registration (amended)
6:32am
10-Q
EX-3.1
c8e6b x8tasr13k70i
14 Oct 20
Quarterly report
4:02pm
S-1/A
EX-3.2
t9alw
20 Jul 20
IPO registration (amended)
6:32am
S-3ASR
EX-4.4
ibeqt73ui 3hlg
4 Aug 21
Automatic shelf registration
4:11pm
8-K
EX-10.1
hav7nqvwg2eb0h
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-4.1
prj3an23rc u3117xvq
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-4.1
k3u mxts4
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
S-1
EX-10.10
p5k 3mzcy6fxm5izf69s
2 Jul 20
IPO registration
4:04pm